- Home
- OCTO vs BDRX Comparison
OCTO vs BDRX Comparison
Compare OCTO & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCTO
- BDRX
- Stock Information
- Founded
- OCTO 1966
- BDRX 2000
- Country
- OCTO United States
- BDRX United Kingdom
- Employees
- OCTO N/A
- BDRX N/A
- Industry
- OCTO
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- OCTO
- BDRX Health Care
- Exchange
- OCTO Nasdaq
- BDRX Nasdaq
- Market Cap
- OCTO 4.2M
- BDRX 3.8M
- IPO Year
- OCTO N/A
- BDRX N/A
- Fundamental
- Price
- OCTO $24.11
- BDRX $5.93
- Analyst Decision
- OCTO
- BDRX
- Analyst Count
- OCTO 0
- BDRX 0
- Target Price
- OCTO N/A
- BDRX N/A
- AVG Volume (30 Days)
- OCTO 11.3M
- BDRX 49.7K
- Earning Date
- OCTO 08-19-2025
- BDRX 09-29-2025
- Dividend Yield
- OCTO N/A
- BDRX N/A
- EPS Growth
- OCTO N/A
- BDRX N/A
- EPS
- OCTO N/A
- BDRX N/A
- Revenue
- OCTO $43,871,615.00
- BDRX N/A
- Revenue This Year
- OCTO N/A
- BDRX N/A
- Revenue Next Year
- OCTO N/A
- BDRX N/A
- P/E Ratio
- OCTO N/A
- BDRX N/A
- Revenue Growth
- OCTO N/A
- BDRX N/A
- 52 Week Low
- OCTO $0.98
- BDRX $5.00
- 52 Week High
- OCTO $83.12
- BDRX $108.90
- Technical
- Relative Strength Index (RSI)
- OCTO 64.39
- BDRX 42.70
- Support Level
- OCTO $1.35
- BDRX $5.00
- Resistance Level
- OCTO $83.12
- BDRX $5.96
- Average True Range (ATR)
- OCTO 7.18
- BDRX 0.53
- MACD
- OCTO 3.60
- BDRX 0.09
- Stochastic Oscillator
- OCTO 27.83
- BDRX 47.21
About OCTO Eightco Holdings Inc.
Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.